QCG
NVCR icon

Quadrant Capital Group’s NovoCure NVCR Stock Holding History

Quadrant Capital Group’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-41
Closed -$530 – 2759
2025
Q3 		$530 Buy
+41
New +$548 ﹤0.01% 2611
2025
Q2 		– Sell
-969
Closed -$17.3K – 2174
2025
Q1 		$17.3K Sell
969
-526
-35% -$11.9K ﹤0.01% 2076
2024
Q4 		$44.6K Buy
1,495
+296
+25% +$6.26K ﹤0.01% 1485
2024
Q3 		$18.7K Sell
1,199
-246
-17% -$4.46K ﹤0.01% 1921
2024
Q2 		$24.8K Buy
1,445
+1,112
+334% +$19.6K ﹤0.01% 1757
2024
Q1 		$5.21K Buy
333
+117
+54% +$1.72K ﹤0.01% 2305
2023
Q4 		$3.23K Buy
216
+68
+46% +$910 ﹤0.01% 2374
2023
Q3 		$2.39K Buy
148
+100
+208% +$2.88K ﹤0.01% 2345
2023
Q2 		$1.99K Sell
48
-138
-74% -$8.57K ﹤0.01% 2415
2023
Q1 		$11.2K Sell
186
-81
-30% -$6.47K ﹤0.01% 1986
2022
Q4 		$19.6K Sell
267
-127
-32% -$9.56K ﹤0.01% 1668
2022
Q3 		$30K Sell
394
-56
-12% -$4.37K ﹤0.01% 1323
2022
Q2 		$31K Sell
450
-151
-25% -$11.4K ﹤0.01% 1084
2022
Q1 		$50K Buy
601
+383
+176% +$28.2K 0.01% 922
2021
Q4 		$16K Buy
218
+167
+327% +$16.8K ﹤0.01% 1406
2021
Q3 		$6K Sell
51
-96
-65% -$14.5K ﹤0.01% 1813
2021
Q2 		$33K Buy
147
+75
+104% +$14.6K ﹤0.01% 1001
2021
Q1 		$10K Buy
72
+65
+929% +$10.3K ﹤0.01% 1502
2020
Q4 		$1K Buy
7
+3
+75% +$411 ﹤0.01% 2161
2020
Q3 		$0 Buy
+4
New +$320 ﹤0.01% 2260
2019
Q4 		– Sell
-76
Closed -$5K – 2467
2019
Q3 		$5K Buy
+76
New +$6.08K ﹤0.01% 1924

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Quadrant Capital Group's NVCR Position: Q4 2025 in Review

Quadrant Capital Group sold out of NovoCure (NVCR) in Q4 2025, closing a stake of 41 shares — an estimated $530 sold.

Quadrant Capital Group first reported a position in NVCR in Q3 2019 and held it in 21 quarters. The position peaked at $50K in Q1 2022. 238 funds tracked by Wall St. Rank hold NVCR as of Q4 2025.

  • Quadrant Capital Group reported no remaining NovoCure position as of Q4 2025 after selling out during the quarter.
  • Quadrant Capital Group sold 41 NovoCure shares in Q4 2025, an estimated $530.
  • Quadrant Capital Group first reported a position in NovoCure in Q3 2019 and held it in 21 quarters.
  • Quadrant Capital Group's NovoCure position peaked at $50K in Q1 2022.
  • 238 funds tracked by Wall St. Rank held NovoCure as of Q4 2025.

Based on Quadrant Capital Group's 13F filing for Q4 2025, filed 13 Feb 2026.